According to Ivan Kunyankin, Data Science Team Lead at Devexperts, the new solution requires only a few weeks of trading data to start generating insights.

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.